Table 3.
Dependent variable | Independent variables | Total sample* | Unadjusted | Adjusted | ||||
---|---|---|---|---|---|---|---|---|
OR | 95% CI | P-value | OR | 95% CI | P-value | |||
Limitations in ADLs | ||||||||
Number of patients | 40 | |||||||
Sex, males vs. females∧ | 0.60 | 0.17–2.16 | 0.43 | 0.77 | 0.17–3.56 | 0.74 | ||
Modified H&Y stage | 5.32 | 1.67–16.93 | 0.005 | 6.54 | 1.79–23.78 | 0.004 | ||
Disease duration, y | 0.97 | 0.88–1.07 | 0.57 | 0.92 | 0.81–1.05 | 0.21 | ||
Degrees | 1.01 | 0.95–1.07 | 0.71 | 1 | 0.94–1.07 | 0.94 | ||
Motor impairment | ||||||||
Number of patients | 40 | |||||||
Sex, males vs. females∧ | 0.86 | 0.25–3.05 | 0.82 | 1.61 | 0.33–7.77 | 0.55 | ||
Modified H&Y stage | 4.64 | 1.57–13.74 | 0.006 | 6.03 | 1.67–21.67 | 0.006 | ||
Disease duration, y | 0.98 | 0.89–1.08 | 0.78 | 0.96 | 0.85–1.09 | 0.57 | ||
Degrees | 1.05 | 0.98–1.11 | 0.17 | 1.06 | 0.97–1.15 | 0.16 | ||
Back pain | ||||||||
Number of patients | 40 | |||||||
Sex, males vs. females∧ | 2.09 | 0.52–8.46 | 0.30 | 1.65 | 0.36–7.64 | 0.52 | ||
Modified H&Y stage | 0.62 | 0.26–1.45 | 0.27 | 0.66 | 0.26–1.67 | 0.38 | ||
Disease duration, y | 0.98 | 0.89–1.08 | 0.70 | 0.95 | 0.85–1.06 | 0.36 | ||
Degrees | 0.94 | 0.88–1 | 0.06 | 0.93 | 0.87–1 | 0.06 | ||
Falls | ||||||||
Number of patients | 40 | |||||||
Sex, males vs. females∧ | 2.22 | 0.62–7.98 | 0.22 | 3.74 | 0.85–16.51 | 0.08 | ||
Modified H&Y stage | 1.70 | 0.76–3.81 | 0.19 | 2.15 | 0.84–5.46 | 0.11 | ||
Disease duration, y | 0.96 | 0.88–1.06 | 0.48 | 0.97 | 0.87–1.08 | 0.59 | ||
Degrees | 1.04 | 0.98–1.11 | 0.18 | 1.05 | 0.98–1.13 | 0.17 |
CI, confidence interval; H&Y, Hoehn and Yahr; OR, Odds Ratio; PAD, Parkinson disease; ∧, denote the reference category; FTB, forward trunk bending;
The total sample included the isolated lower FTB (n = 27) and combined forms (upper + lower FTB, n = 13); significant associations in bold at p < 0.05.